ARK Innovation ETF (ARKK)

41.06
Delayed Data
As of Feb 16
 -0.03 / -0.07%
Today’s Change
22.70
Today|||52-Week Range
42.55
+10.73%
Year-to-Date

Investment Objective

The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund's investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The advisor currently intends to use only American Depositary Receipts ("ADRs") when purchasing foreign securities. The fund is non-diversified.

Log In to Social Media ETFs on Twitter's Strength
Feb 12 / Zacks.com - Paid Partner Content
ETFs in Focus on Tesla Q4 Earnings Beat, Model 3 Target
Feb 08 / Zacks.com - Paid Partner Content

Performance

1 month+5.50% 3 years+25.51%
3 months+17.81% 5 years--
1 year+80.49% Since inception+25.53%
Data through 02/17/2018

Quote Details

Previous close$41.09
Open day’s range40.91 – 41.45
Net asset value (NAV)40.89 (02/16/2018)
Daily volume287,426
Average volume (3 months)309,038
Data as of 8:00pm ET, 02/16/2018

Peer Comparisonvs. Technology ETFs

 ARKKCategory
Performance 5-yr return--+19.49%
Expense Gross exp ratio0.75%1.40%
Risk 5 year sharpe ratio--1.37
Net assets$550.9M$1.3B
Average market cap$8.3B$44.8B
Average P/E--27.6
Dividend / Share--0.14%

Competitors

XNTK SPDR® NYSE Technology ETF
XLK Technology Select Sector SPDR® Fund
IGM iShares North American Tech ETF

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
GBTC Bitcoin Investment Trust6.17%
TSLA Tesla5.60%
TWTR Twitter5.09%
SSYS Stratasys Ltd4.70%
ATHN athenahealth Inc4.42%
ILMN Illumina Inc3.65%
NTLA Intellia Therapeutics Inc3.58%
AMZN Amazon3.44%
EDIT Editas Medicine Inc3.36%
JUNO Juno Therapeutics Inc3.29%